Global Knee Hyaluronic Acid Injections Market, by Injection Type (Single Injection Knee Hyaluronic Acid Injections, Three Injection Knee Hyaluronic Acid Injections, Five Injection Knee Hyaluronic Acid Injections, Next Generation (Steroid Combination)), By End-Use (Hospitals, Ambulatory Surgical Centers, Other End-Uses), and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Knee Hyaluronic Acid Injections Маrkеt Overview

The global knee hyaluronic acid injections market is projected to reach a valuation of USD 3,094.90 Mn by 2031 at a CAGR of 5.00%, from USD 1,900.00 Mn in 2021.

“Global Knee Hyaluronic Acid Injections Market, by Injection Type (Single Injection Knee Hyaluronic Acid Injections, Three Injection Knee Hyaluronic Acid Injections, Five Injection Knee Hyaluronic Acid Injections, Next Generation (Steroid Combination)), By End-Use (Hospitals, Ambulatory Surgical Centers, Other End-Uses), and by Region – Global Forecast to 2031”. This report offers a holistic view of the global knee hyaluronic acid injections market through systematic segmentation that covers every aspect of this target market.

The knee is one of the most common joints with a high probability of needing to be replaced in the future. The knee has many structures; when one wears down, it can affect an individual’s mobility. One such issue is arthritis, which can lead to discomfort, pain, swelling, stiffness, and more. A new treatment for these issues called hyaluronic acid injections may provide relief for patients.

A common knee injury, osteoarthritis, results from the cartilage around the knee wearing down. This can occur because of an accident or as a result of natural aging. Knee hyaluronic acid injections are a treatment option to halt or slow down that process by injecting it into the affected area. It is then absorbed into the cartilage and stays there for up to 3-6 months, depending on how many injections are administered. Knee injuries can devastate your physical fitness and ability to get around. Until now, the only two options for treatment were pain medication or surgery. But there is now a new option of Hyaluronic Acid (HA) injections administered by needle injection of the joint. Knee hyaluronic acid injections are a safe and effective treatment to help relieve pain caused by arthritis. It involves the injection of knee joint fluid, also known as synovial fluid, which surrounds and protects your joints. Numerous medical professionals now believe knee hyaluronic acid injections are an excellent treatment solution for those who suffer from arthritis in their knees. These injections take a few minutes and can provide significant relief and pain reduction without surgery. Knee Hyaluronic acid injections are a common drug for relieving chronic knee pain. They work by keeping the joints lubricated and reducing inflammation. These injections can be done as an outpatient or overnight hospital stay.

The use of injections for knee pain is rising, but it’s not always the best option. When chronic conditions affect your knees, surgery may be necessary to get relief. However, if a patient has a more recent injury or doesn’t have any other underlying health issue, injections are a great way to get relief from short-term pain. A patient can get two shots in one visit or less than 20 minutes after the first injection.

Global Knee Hyaluronic Acid Injections Market Revenue (US$ Mn), 2021–2031

Source: Prudour, 2021

The demand for various healthcare management programs and the availability of minimally invasive treatment options is increasing as knowledge grows. Combined with this, increased investments in innovative breakthroughs and creative product lines are likely to boost market sales at a rapid rate. Current sales figures are being driven by the availability of low-cost alternatives to high-cost knee osteoarthritis surgery. Other important factors propelling this market growth are expansion and product introductions in emerging markets. These are certain factors that are anticipated to help augment this market in the years to come.

Although viscosupplementation has advantages such as increased efficacy and a faster recovery time, there are certain adverse effects linked with its use. Temporary pain at the injection site, itching, redness, swelling, bruising around the joint, and fluid collection in the injected knee are all common side effects that are usually moderate and do not last long. Another issue could be strict reimbursement rules in developed and emerging nations to regard sodium hyaluronic acid injections as a better treatment alternative and the limits of treatment cycle frequency.

In the coming years, this industry is expected to benefit from the active participation of organizations in developing business prospects through acquisitions and alliances to improve their existing portfolio. Additionally, obesity and age-related health conditions, such as joint damage and knee osteoarthritis, have become a major source of concern. Knee osteoarthritis is a degenerative musculoskeletal disorder that causes severe pain in patients as they age and can lead to further disability if left untreated. As a result, the need for improved medical care and better healthcare services has skyrocketed. Moreover, due to factors such as superior efficacy, fewer side effects, and minimal patient discomfort, the rapid development, and commercialization of knee hyaluronic acid injections have created a huge opportunity for this market, as an increasing number of osteoarthritic patients are looking for a safe, affordable, and effective procedure. These factors are expected to create lucrative opportunities for existing and emerging players in this market.

This research report on the global knee hyaluronic acid injections market includes major company profiles such as

• Sanofi S.A.
• Seikagaku Corporation
• Biochimique SA, Fidia
• Farmaceutici S.p.A.
• Anika Therapeutics Inc.
• Zimmer Biomet
• Viatrus Inc.
• Chugai Pharmaceuticals Co. Ltd.
• Haohai Biological Technology
• Hanmi Pharm Co. Ltd., among others.

In May 2021, Ono and Seikagaku announced that JOYCLU® 30mg intra-articular injection, a joint function improvement agent, had received manufacturing and marketing authorization in Japan to treat osteoarthritis (Knee Joint and Hip Joint).

The Global Knee Hyaluronic Acid Injections Market Segmentation is Based on Injection Type, End-Use, and Region

Based on Injection Type

• Single Injection Knee Hyaluronic Acid Injections
• Three Injection Knee Hyaluronic Acid Injections
• Five Injection Knee Hyaluronic Acid Injections
• Next Generation (Steroid Combination)

Based on End-Use

• Hospitals
• Ambulatory Surgical Centers
• Other End-Uses

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

For the Knee Hyaluronic Acid Injections Маrkеt research study, the following years have been considered to estimate the market size: